HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 (GLP-1) medications are a class of drugs that mimic the effects of the naturally occurring hormone GLP-1 in the body. This hormone plays a crucial role in regulating appetite, insulin secretion, and blood sugar levels. When GLP-1 is released after eating, it signals the pancr

Mechanisms of Action: How GLP-1 Works

GLP-1 medications work through several mechanisms that contribute to weight loss and improved metabolic health:

  1. Appetite Regulation: GLP-1 reduces hunger signals in the brain, leading to decreased food intake. This is particularly beneficial for those struggling with cravings and overeating.
  2. Insulin Secretion: By enhancing insulin secretion in response to meals, GLP-1 helps lower blood sugar levels, making it a valuable treatment for individuals with type 2 diabetes.
  3. Delayed Gastric Emptying: These medications slow the emptying of the stomach, which prolongs the feeling of fullness after meals and helps prevent overeating.
  4. Weight Loss: Clinical studies have shown that GLP-1 medications can lead to substantial weight loss. For instance, participants taking semaglutide have lost an average of 15% of their body weight over 68 weeks.

By harnessing these mechanisms, GLP-1 medications offer a powerful tool for individuals seeking to manage their weight and improve their overall health.

Standard Dosing Protocols for GLP-1 Medications

When initiating treatment with GLP-1 medications, healthcare providers typically follow a structured dosing protocol. The goal is to find the minimum effective dose that maximizes weight loss while minimizing side effects. Understanding the lowest dose of GLP-1 medications is essential for tailoring treatment to individual needs.

For many GLP-1 medications, the starting dose is designed to help the body acclimate to the medication. For example:

  • Semaglutide (Ozempic®): The initial dose is often 0.25 mg once weekly for the first four weeks. This dose is not intended for glycemic control but serves as an introductory measure to reduce gastrointestinal side effects.
  • Liraglutide (Saxenda®): The starting dose is usually 0.6 mg daily, which can be increased after a week to 1.2 mg, depending on tolerance and treatment goals.

After the initial phase, the dose may be gradually increased based on individual response and tolerability. This titration process ensures that patients receive an effective dose without overwhelming side effects. Here’s a typical progression:

  • Semaglutide: After four weeks at the starting dose, the dose may be increased to 0.5 mg weekly. Further increases can occur at four-week intervals, with a maximum dose of 2.4 mg weekly for weight management.
  • Liraglutide: After the starting dose, it can be increased to 1.2 mg daily and then to a maximum of 3.0 mg daily as needed.

The Role of Microdosing in GLP-1 Treatment

In recent discussions around GLP-1 medications, the concept of microdosing has emerged. Microdosing refers to taking smaller-than-standard doses of medication to reduce side effects while still achieving treatment goals.

  1. Reduced Side Effects: Many patients experience gastrointestinal side effects when starting GLP-1 medications. Microdosing may help alleviate these symptoms, making it easier for individuals to stick with their treatment.
  2. Flexible Dosing: Microdosing allows for more customized treatment plans that cater to individual needs. Patients can work with their healthcare providers to determine the minimum effective dose necessary to achieve their goals.
  3. Improved Adherence: By minimizing side effects and allowing for a gradual increase in medication, microdosing can enhance patient adherence to their treatment plans.

While microdosing offers potential benefits, it’s important to note that it is not without challenges. The FDA does not currently have established guidelines for microdosing GLP-1 medications, and more research is needed to understand the long-term effects of lower doses.

Patients considering this approach should always consult with their healthcare providers to determine the best course of action for their weight loss journey.

FAQ

What is the lowest dose of GLP-1 medications?

How long do I need to stay on the lowest dose?

Are there any side effects associated with GLP-1 medications?

How can I get started with GLP-1 medications?

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider a pharmacogenomic foundation before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from 503B-registered outsourcing facilities meeting federal CGMP standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the lowest dose of GLP-1 medications?

The lowest dose varies by medication. For example, semaglutide starts at 0.25 mg weekly, while liraglutide starts at 0.6 mg daily. These initial doses are designed to help patients acclimate to the medication.

How long do I need to stay on the lowest dose?

Typically, the lowest dose is maintained for about four weeks to assess tolerance before increasing to a higher dose if needed. Your healthcare provider will guide you based on your individual response.

Are there any side effects associated with GLP-1 medications?

Common side effects may include nausea, vomiting, diarrhea, and gastrointestinal discomfort. Starting at a low dose and gradually increasing can help mitigate these effects.

Can anyone take GLP-1 medications?

While GLP-1 medications are generally safe, they may not be suitable for everyone. Individuals with certain medical conditions, such as a history of pancreatitis or thyroid cancer, should avoid these medications. Always consult with your healthcare provider before starting any new medication.

How can I get started with GLP-1 medications?

To explore if GLP-1 medications might be right for you, we invite you to take PlexusDx's free assessment quiz. Simply visitthis linkto begin your journey.

Related Reading

Pricing and availability current as of May 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves